Quantitation of N-Nitroso Nebivolol in Nebivolol Tablet Formulation

Applications | 2025 | Agilent TechnologiesInstrumentation
LC/MS/MS, LC/MS, LC/QQQ
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Analysis of N-nitroso-nebivolol, Nitroso Drug Substance Related impurity in Nebivolol 20 mg tablet formulation using LC-MS/MS system
Quantitation of N-Nitroso Moxifloxacin in 400 mg Moxifloxacin Tablet Formulation
Quantitation of N-Nitroso Hydrochlorothiazide in Losartan- Hydrochlorothiazide Tablets
Determination of Genotoxic Nitrosamine Impurity in Bumetanide API and Tablets Using the Agilent 6470 Triple Quadrupole LC/MS